普利製藥(300630.SZ):兩股東擬合計清倉減持不超2.4%股份
格隆匯 8 月 31日丨普利製藥(300630.SZ)公佈,海南普利製藥股份有限公司董事會於2020年8月31日收到股東金賽普、泰捷的《減持股份告知函》。
持有公司股份965.2703萬股(佔公司總股本比例2.22%)的股東北京金賽普企業管理有限公司(統一社會信用代碼:91330100563023425E,“金賽普”)計劃在公告披露日起15個交易日後的6個月內通過集中競價減持不超過870.1765萬股,不超過公司總股本的2%;從公告披露日起3個交易日後的6個月內通過大宗交易減持不超過965.2703萬股,不超過公司總股本的2.22%。合計擬減持數量不超過965.2703萬股,即不超過公司總股本的2.22%。
持有公司股份81.1137萬股(佔公司總股本比例0.19%)的股東北京泰捷企業管理有限公司(統一社會信用代碼:913301025898788009,“泰捷”)計劃在公告披露日起15個交易日後的6個月內通過集中競價減持不超過81.1137萬股,不超過公司總股本的0.19%;從公告披露日起3個交易日後的6個月內通過大宗交易減持不超過81.1137萬股,不超過公司總股本的0.19%。合計擬減持數量不超過81.1137萬股,即不超過公司總股本的0.19%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.